Potential risks of chronic sildenafil use for priapism in sickle cell disease

Journal of Sexual Medicine

Volumn 8, Issue 11, 2011, Pages 3193-3195

  Lane, Andrew ^a   Deveras, Ruby ^a  

^a FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Pathophysiology of sickle cell recurrent priapism; Priapism; Sickle cell; Sildenafil

Indexed keywords

EPHEDRINE; SILDENAFIL;

ADULT; ARTICLE; CASE REPORT; CHRONIC DISEASE; DRUG USE; DRUG WITHDRAWAL; HEALTH STATUS; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MALE; PAIN; PRIAPISM; PRIORITY JOURNAL; RECURRENT DISEASE; RISK; SEXUAL BEHAVIOR; SEXUAL SATISFACTION; SICKLE CELL ANEMIA; SLEEP QUALITY; VASOOCCLUSIVE PAIN CRISIS;

EID: 80255136302     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02440.x     Document Type: Article

References (12)

1. Huang YC, Harraz AM, Shindel AW, Lue TF. Evaluation and management of priapism: 2009 update. Nat Rev Urol 2009;6:262-71.
2. Rogers ZR. Priapism in sickle cell disease. Hematol Oncol Clin North Am 2005;19:917-28, viii.
3. Olujohungbe AB, Adeyoju A, Yardumian A, Akinyanju O, Morris J, Westerdale N, Akenova Y, Kehinde MO, Anie K, Howard J, Brooks A, Davis VA, Khoriatry AI. A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: Report of an international randomized control trial; The Priapism In Sickle Cell Study (PISCES study). J Androl 2011;32:375-82.
4. Bennett N, Mulhall J. Sickle cell disease status and outcomes of African-American men presenting with priapism. J Sex Med 2008;5:1244-50.
5. Burnett AL, Bivalacqua TJ, Champion HC, Musicki B. Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology 2006;67:1043-8.
6. Burnett AL, Bivalacqua TJ, Champion HC, Musicki B. Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. J Sex Med 2006;3:1077-84.
7. Burnett AL. Molecular pharmacotherapeutic targeting of PDE5 for preservation of penile health. J Androl 2008;29:3-14.
8. NHLBI stops study of treatment for pulmonary hypertension in patients with sickle cell disease due to safety concerns. National Institutes of Health; 2009.
9. Bivalacqua TJ, Musicki B, Hsu LL, Gladwin MT, Burnett AL, Champion HC. Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism. J Sex Med 2009;6:2494-504.
10. Claudino MA, Franco-Penteado CF, Corat MA, Gimenes AP, Passos LA, Antunes E, Costa FF. Increased cavernosal relaxations in sickle cell mice priapism are associated with alterations in the NO-cGMP signaling pathway. J Sex Med 2009;6:2187-96.
11. Dai Y, Zhang Y, Phatarpekar P, Mi T, Zhang H, Blackburn MR, Xia Y. Adenosine signaling, priapism and novel therapies. J Sex Med 2009;6(3 suppl):292-301.
12. Wen J, Jiang X, Dai Y, Zhang Y, Tang Y, Sun H, Mi T, Kellems RE, Blackburn MR, Xia Y. Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism. J Sex Med 2010;7:3011-22.